Tiotropium versus placebo for inadequately controlled asthma: A meta-analysis

Respiratory Care

Volumn 59, Issue 5, 2014, Pages 654-666

  Tian, Jing Wei ^a   Chen, Jin Wu ^a   Chen, Rui ^a   Chen, Xin ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Anticholinergics; Asthma; Inadequately controlled asthma; Meta analysis; Tiotropium

Indexed keywords

PLACEBO; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; SCOPOLAMINE DERIVATIVE;

ARTICLE; ASTHMA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFECTION; LUNG FUNCTION; MENTAL DISEASE; META ANALYSIS; MODERATE PERSISTENT ASTHMA; MUSCULOSKELETAL DISEASE; NEOPLASM; NEUROLOGIC DISEASE; PEAK EXPIRATORY FLOW; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; SEVERE PERSISTENT ASTHMA; SPIROMETRY; VASCULAR DISEASE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECTS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

ASTHMA; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; FORCED EXPIRATORY VOLUME; HUMANS; PLACEBOS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCOPOLAMINE DERIVATIVES; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 84899734162     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02703     Document Type: Article

References (30)

1. Fanta CH. Asthma. N Engl J Med 2009;360(10):1002-1014.
2. Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. Updated 2012. http://www.ginasthma.org. Accessed May 12, 2013.
3. Matera MG, Cazzola M. Ultra-long-acting beta2-adrenoceptor agonists: an Emerging therapeutic option for asthma and COPD? Drugs 2007;67(4):503-515.
4. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359(15):1543-1554.
5. Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev 2004;3:CD003269.
6. Casale TB, Eucklund P. Characterization of muscarinic receptor subtypes on human peripheral lung. J Appl Physiol 1988;65(2):594-600.
7. Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci 1993; 52(5-6):521-527.
8. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Report of the GOLD Workshop: Global Strategy for Diagnosis, Management and Prevention of COPD. Updated 2012. http://www.goldcopd.com. Accessed May 12, 2013.
9. Ohta S, Oda N, Yokoe T, Tanaka A, Yamamoto Y, Watanabe Y, et al. Effect of tiotropium bromide on airway inflammation and remodeling in a mouse model of asthma. Clin Exp Allergy 2010;40(8):1266-1275.
10. Buels KS, Jacoby DB, Fryer AD. Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma. Br J Pharmacol 2012;165(5):1501-1514.
11. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, et al. Tiotropium bromide step-up therapy for adults with poorly controlled asthma. N Engl J Med 2010;363(18):1715-1726.
12. Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16 Arg/Arg patients with asthma. J Allergy Clin Immunol 2011;128(2):315-322.
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17(1):1-12.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-188.
15. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998;316(7124):61-66.
16. Kerstjens HA, Disse B, Schroder-Babo W, Bantje TA, Gahlemann M, Sigmund R, et al. Tiotropium improves lung function in patients with severe poorly controlled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011;128(2):308-314.
17. Efficacy and safety of 3 doses of tiotropium compared to placebo in adolescents (12 to 17 Yrs) with moderate asthma. Updated 2012. http://clinicaltrial.gov/ct2/show/NCT01122680. Accessed May 12, 2013.
18. Randomised, double-blind, cross-over efficacy and safety comparison of three different doses of tiotropium administered once daily versus placebo in patients with moderate persistent asthma. http:// clinicaltrial.gov/ct2/show/NCT01152450. Accessed May 12, 2013.
19. A randomised, double-blind, placebo controlled, cross-over efficacy and safety comparison of tiotropium 5 g once daily and tiotropium 2.5 g twice daily for four weeks in patients with moderate persistent asthma. http://clinicaltrial.gov/ct2/show/NCT01233284. Accessed May 12, 2013.
20. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 1999;14(1):23-27.
21. National Institutes of Health, National Heart, Lung and Blood Institute. Global initiative for asthma; global strategy for asthma management and prevention. National Institutes of Health, Publication 02-3659, 2002.
22. van Noord JA, Aumann JL, Janssens E, Smeets JJ, VVerhaert J, Disse B, et al. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J 2005;26(2):214-222.
23. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004;170(8):836-844.
24. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med 2008;102(1):50-56.
25. Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 2007;101(6):1218-1228.
26. O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996;154(4):876-880.
27. Sposato B, Barzan R, Calabrese A, Franco C. Comparison of the protective effect amongst anticholinergic drugs on methacholineinduced bronchoconstriction in asthma. J Asthma 2008;45(5):397-401.
28. Terzano C, Petroianni A, Ricci A, D'Antoni L, Allegra L. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness. Eur Rev Med Pharmacol Sci 2004;8(6):259-264.
29. Singh S, Loke YK, Enright PL, Furberg CD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2011;342:d3215.
30. Juniper EF, Svensson K, Mork AC, Ståhl E. Measuring health-related quality of life in adults during an acute asthma exacerbation. Chest 2004;125(1):93-97.